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One of the most widespread and ancient of biological 
processes, found in both prokaryotes and eukaryotes, is 
the cytochrome-based electron transfer mechanism. Variations 
of this process are found in photosynthesis, in respiratory 
chains using oxygen, nitrate, and sulfate, and in synthetic 
pathways for steroiie (1), The most accessible member of this 
family of electron carriers is cytochrome c, a peripheral 
membrane protein isolated from the mitochondria of eukaryotic 
organisms* In the eukaryotic electron transfer chain, cytochrome c 
is an important protein involved in transferring electrons 
from cytochrome c reductase to cytochrome c oxidase. Its 
3-dimensional structure has been well documented for a number 
of different organisms using x-ray crystallography. In 
addition, its amino acid sequence has been found to be 
remarkably well conserved for a number of different species.
This conservatism has led to the use of cytochrome c amino 
acid sequences to elucidate phylogenetic trees (2,3).
Although the structure of cytochrome c is well known, 
the mechanism of its electron transfer is still to be solved.
The most widely accepted model is an "outer sphere" electron 
transfer mechanism involving the exposed heme edge of 
cytochrome c. Other models include temperature independent 
nuclear tunneling, direct conjugation transfer of electrons 
involving aromatic side chains, and the bond theory of 
electron transfer (4)*
( D
One approach to elucidate the mechanism of electron 
transfer, therefore, involves following the kiaeties of 
electron transfer between cytochrome c and a series of small 
molecule redox agents. By using Marcus theory and having 
some knowledge of the thermodynamics of a particular reaction, 
some information about the mechanism may be obtained.
However, even a structurally characterised metalloprotein 
like cytochrome c still presents a problem too complex to 
handle for some theoretical studies. One way to circumvent 
this problem is to use heme peptides derived from proteolytic 
digestion of cytochrome o as simpler models to elucidate the 
mechanism of native oytochrome c eleotron transfer (5).
One of the heme peptides to be used in studying electron 
transfer is the heme undecapeptide (HP-11, residues 11-21), 
obtained from pepsin digestion of cytochrome o ( 6). Its 
amino acid sequence has been determined (7) (figures 1,2).
Moreover, its properties indicate that it is different from
its parent protein in many ways. Native cytochrome c is a
roughly spherical 12,500 M.V. protein with little0<*-helix and
no"&-pleated sheets. In fact, the polypeptide is almost
entirely wrapped around the heme. The heme group is surrounded
by many tightly packed hydrophobic side chains and is covalently
linked to the protein by two thioether linkages through
cysteine-14 and cysteine*17. The iron atom is bound to the
sulfur atom of methionine-80 and the nitrogen atom of histidine-18 (8)
(figure 2).
HP-11, on the other hand, has been predicted to be 
ot-helical in structure by moleeular modeling (9) •
2
3In addition, Chou and Fasman rules, applied to the heme 
peptide, indicate a strong tendency for the ^ -helical structure 
(<?>* 1.16 ) (10). Molecular models also indicate that, 
unlike cytochrome c, the undecapaptide can shield no more 
than a quarter of its heme from the solvent (11). However, 
the heme is still firmly linked to the peptide at cysteine-14 
and cysteine-17. Methionine-.30, on the other hand, is cleaved 
by digestion leaving a free coordination site at the sixth 
position. The fifth coordination position is usually linked 
to the imidazole side chain of histidine-1o as in cytochrome c. 
Situations in which the histidine-18 is not coordinated to 
the iron will be discussed later.
Not only is the structure of HP-11 different from 
cytochrome c, many of its properties are also unique. Whereas 
cytochrome c will not bind to any ligands between pH 3 and 12, 
HP-11, with its free 3ixth coordination position will combine 
with a number of ligands including CO, CN, imidazole, and other 
heme peptides (6,10,13-16). In addition, the reduction 
potential of cytochrome c (+.25) has been reduced to -.180 
for HP-11 at pH 7. The isoelectric point of cytochrome c (10.7) 
is now reduced to a pi of 4.75 in HP-11 (17*18)# Moreover, 
peroxidative activity in HP-11 has been determined to be 
150 times that of native cytochrome c (12).
HP-11, therefore, is an unique peptide. Its properties 
have found many applications. It has been used as a CO 
scavenger in determining the rate constants for CO dissociation 
from hemoglobin (13). In addition, its peroxidative activity
4has enable it to be used as a nontoxic uitrastructural tracer 
for tissue and cellular compartments (12).
Moreover, HP-11fs relatively unshielded heme group, 
wide pH solubility, and structural simplicity may be used to 
help elucidate the electron transfer mechanism of cytochrome c*
Its relatively unprotected heme group may be used in ionic 
strength dependence studies to determine the effect of 
electrostatic interactions on electron transfer reactivity*
In addition, its solubility over a wide pH range allows the 
study of the effects of ionization Gf specific residues 
on electron transfer rates* Moreover, whereas extensive procedures 
arc required to isolate specifically modified isomers of 
cytochrome c, HP-11’s structural simplicity allows for 
simple chemical modification of specific amino acid residues 
and their subsequent isolation. These chemically modified 
nemo peptidos may then be used to determine the effects of 
a specific amino acid residue on peptide reactivity (5)*
The project that was pursued, therefore, had three specific 
purposes. First, the purification of HP-11 was begun in order 
to provide the umiecapeptide for the studies described above. 
Jecondly, spectral anaiysis of HP-11 was undertaken in order 
to characterize the heme peptide, La3t of all, the techniques 
visit were developed and employed in both cases may then oe 
applied to tile characterization of other heme peptides.
Figure ^-Schematic structure df heme peptides of 
~ cytochrome c
HP-11 (amino acid residues 11-21)
HP-9 iamino acid residues 14-22)
HP-8 (amino acid residues 14-21)
from Warme,1969
Figure 2-Backbone structure of cytochrome c.
~ Amino acid residues and the heme making 
up HP-11 are shaded, 
from Lehninger,1982
5Figure 1
Figure 2
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6Purification of HP-11
A. Introduction
HP-11 was first purified by partition chromatography 
following pepsin digestion at pH 1*5 (7)* However, it was 
soon noticed that digestion at this low pH often yielded 
two bands upon isoelectric focusing. The main band had a 
pi of 4*75 which was attributed to two glutamate residues 
and one glutamine residue in the heme peptide. The other 
band, containing less than 10# of the total sample had a 
pi of 4*6, This band was interpreted to be due to the hydrolysis 
of the glutamine residue to yield a peptide containing three 
glutamates (19)*
Not only were there problems with the digestion procedure, 
but partition chromatography often required extensive dialysis 
with substantial loss of the peptide. In addition, partition 
chromatography removed basic amino acid impurities better 
than acid ones leading to excess glutamate and significant 
amounts of aspartate as contaminants (20),
Since, then, several new methods in purifying HP-11 have 
been developed including affinity chromatography (21) and 
gel filtration (20,22),
Peterson, et, al, have reported that digestion us.Ang more 
pepsin at pH 2,6 tends to prevent the hydrolysis of the 
glutamine to glutamate. In addition, the use of gel filtration 
in H20 removes the problem of dialysis. Using this procedure, 
they found that the main fraction obtained from their Seph&dex 
G-15 and later G-10 columns yielded a peptide whose amino 
acid sequence agreed with HP-11 (20,23)#
7We have attempted to reproduce the work of Peterson, et al. 
to purify HP-11. However, several difficulties were encountered:
1) A sample of digest purified by gel filtration using 
Biorad P-2 acrylamide gel gave a fraction whose amino acid 
analysis did not agree with published results. 2) An attempt 
was made to increase the purity of the P-2 separated HP-11 by 
DKAE anion exchange chromatography. This procedure failed.
The following discussion details the results obtained and
some methods that could be employed to purify HP-11 ii the future.
b . gad
1• Digestion
500 mg of horse heart cytochrome c (Sigma) were dissolved 
in 100 ml of ^ 0  and the pH adjusted to 2.6 using 1 N HC1. Ten 
milligrams of pepsin (Sigma) were added and the reaction mixture 
was incubated at 27°C for 12 hours using a constant temperature 
water bath. After 12 hours, the pH of the solution was 
readjusted to 2.6, and another 10 mg of pepsin was added.
The incubation was continued for another 12 hours. At the 
end of the digestion, the mixture was brought up to a final 
pH 9.0 using .880 ammonia/^ 0 (20,25).
2. £el filtration
Gel chromatography was performed using a 20x3*0 cm P-2 
column. A steady elution rate was maintained using a Ilieroperpex 
pump connected to a fraction collector. The elution was monitored 
through an ISCO column monitor, Ten ml of the digest were 
then concentrated using a vacuum pump line. A spectrum 
of the digest was taken to estimate the correct absorbance 
range for the calibrated column monitor. The concentrated 
digest (approx. .5 ml) was then loaded onto a P-2 column
9which had been previously equilibrated with HgO. The digest 
was then eluted at 3.0 ml/hr using degassed HgO, and its 
progress was monitored at 234 nm. The fractions containing 
the main peak were identified from the elution profile.
Ten ul samples from the appropriate test tubes were then 
blotted onto a piece of TLC paper. Ninhydrin was 3prayed 
uniformly, and the paper was put into the oven for 10 minutes. 
The resulting purple spots indicated the presence of amino 
acid contaminants. The uncontaminated portion of the main 
peak was then collected. Other peaks in the elution profile 
were also ^ed. A spectrum of the eluted peaks was taken.
3. BEAE Purification
BEAK elution was attempted using: 1) an ionic rf ungth
gradient 2) a constant ionic strength buffer.
An ionic strength gradient was set up using a gradient mixer 
in which 50 ml of u«.Q5 MOPS and 50 ml of u*.5 MOPS (.05 MOPS, 
.45 NaClO^) were gradually mixed together (Figure 3). The 
P-2 purified sample was then loaded onto a HgO equilibrated 
10 x .75 cm DEAD column where it formed a tight red band.
The peptide was eluted using the gradient.
In order to run a constant ionic strength elution, the 
proper ionic strength buffer must be determined. A test 
tube assay was developed for this purpose using MES buffer 
(pK »6.1). A series of 10 x 15 ml test tubes were set up
a
with a range of u»0-.5 in increments of u*.Q5 MES. MES 
of various ionic strengths were made up from a degassed 
li«.Q5 MES stock buffer from which the appropriate amount 
of NaClQ^ was added to bring the buffer to the desired ionic 
strength. 1.5 ml of fairly concentrated DEAE gel was then
9added to each test tube. The gel in each tube was equilibrated 
by wa3hing 10 times with 10 ml of the desired ionic strength 
buffer, A constant amount of P-2 purified HP-11 was then 
added to each tube. After the gel had settledf the absorbance 
of the supernatant was measured at 405 nm. Control absorbances 
of the peptide at various ionic strengths without DEAE were 
also determined.
After selecting for the appropriate ionic strength MESt 
two seta of three ,75 x 10 cm DEAE columns were set up to 
test the validity of the test tube assay. One column was 
eluted using the selected ionic strength MES, the other two 
columns wore udeaired ± .05. A corresponding set was made up 
using MOPS (pK =7.2).dL
Upon selection of the proper ionic strength buffer, 
the entire P-2 purified digest may then be loaded onto 
a 40 x 1.5 cm DEAE column employing a flow adapter and eluted.
C. Hesults and Discussion 
1• Gel Filtration
tfe initially precipitated our digest at pH 5 with ammonium 
sulfite, The precipitated digest, centrifuged to obtain a 
pellet, was then loaded onto a G-15 column (20), It was 
decided in our case, however, that this procedure may leave 
the ammonium ion still linked to the heme iron after purification. 
The resulting HP-11, therefore, may be inappropriate for kinetic 
studies. To avoid this problem, we used a vacuum line to 
concentrate our digest. This procedure, however, does have 
some disadvantages; 1) The precipitation process is a method 
of partially purifying the heme peptide by removing any 
undigested cytochrome c and pepsin. 2) Concentration of
10
the digest by a vacuum line takes approximately 10 hour* 
to concentrate a 10 ml sample to .5 ml*
The concentrated digest was initially eluted from a 
0-15 column at 18 ml/hr. A substantial amount of tailing 
was observed (Figure 4a)• In order to decrease the tailing* 
a finer mesh gel, Biorad P-2, was used. Moreover, the elution 
rate was slowed down to 9 ml/hr (Figure 4b). In both cases, 
elution was monitored at 409 nm. As can be seen, the P-2 column* 
at a slower elution rate,allows better resolution. However, 
in both instances, we observed only one peak. In order to 
detect the presence of any amino acids, the elution was 
monitored at 254 nm and the pump was slowed down to 3 ml/hr.
Three well-resolved peaks were obtained (Figure 4c).
Figure 5 shows the spectra of native cytochrome c, after 
digestion, and P-2 purified HP-11. As can be seen, native 
cytochrome c has a high absorbance in the UV region (330-230 nm) 
with a Soret maximum at 408 nm (Soret-390-420 nm). The 
digest spectrum 3hows that the visible region (600-480 nm) has decreased 
;n absorbance compared to native cytochrome c. Moreover, 
the 8oret maximum has shifted to 406 nra, and the UV peak 
has diminished in intensity. The P-2 purified HP-11 shows 
a further absorbance diminution in the visible region. The 
3oret has shifted to a maximum of 399 nm with complete 
disappearance o f  the absorption peak in the UV.
Figure 6 shows the spectra of the main peaks eluted from the 
P-2 column. As can be seen, the main fraction, which we 
believe contain UP-11, has an absorption maximum at 399 nm 
with little absorbance in the UV. The second peak obtained, 
on the other hand, shows a visible peak shifted from 520 nm
11
to 525 nm# The Soret shifts to a maximum of 406 am with a 
large absorbance in the UV. The last fraction eluted shows 
the disappearance of the visible peal:, the Soret maximum 
at 406 nm, and a large absorbance in the UV# The P-2 spectraf 
therefore, show that three spectrally well-defined fractions 
are obtainod#
Amino acid analysis of the main P-2 fraction, however, 
indicated that the peptide was not completely purified#
Two methods were developed to increase the purity of the P-2 
purified HP-11; 1) Ninhydrin spray 2) DEAJ3 elution#
The Ninhydrin spray was developed in order to detect any amino 
acid contaminants that naght have eluted at the same time with 
the heme peptide* Figu t 4c s i w3 that the amino acids were 
indeed eluted near the m. of t a m a  pea, , I’hese fractions 
were not pooled.
Pro ••ntly, th r-2 eluii n uao oeen worn d ut 1th the following
conditi .ms: 10 u.gi*3t (appr x* 7 • :■ mg C i h  ♦
monitord  it , , x - b * e uited witu doga.;si HgP a
3 ml/hr * ' .1' ,a,.: 1 rray may hen b* u ; to det ct
which 1w r a n pea! she i'ld be or ted.
2. xi xiM: ■'i ■ wi i. -si *1* U4 V 30 X *
£ r ~ration, ur for tuna u y, haa n , worked out a a
well is go. fi ration* The resu ts obtain were often
in a or .. 1231 01.'l » iuwever, urther g rificatior liter P-2
. tra‘ * 01 r no cess ry*
XI goal, v i i i • 1 si v p i r 1 i i.! at#.. * wan two- jid: 1) If
. ;i- eiu t i< gave 3,,ffic.'unt ieparation , a single
-t it" ulo bi reoii 1 upon rdAE luti an. ^  If the P-2 eli Lon
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was not sufficient, the i>EAE column should serve to 
purify the peptide further*
Initially, it was decided that an ionic strength gradient 
would be used to separate the heme peptide* Figured. 7i*»"7b 
show the elution profiles from a 10 x *75 ora ooluran using 
u®.05-.5 MOPS for both P-2 eluted HP-11 and Sigma HP-11.
As can be seen, although similar profiles were obtained 
for our HP-11 and the Sigma standard, no clear resolution was 
obtained. The poor separation was attributed to the poor 
gradient that was produced. It was observed that upon 
allowing the two buffers to mix, a significant amount of 
u».5 MOPS rushed into the u*.05 MOPS container. In addition, 
after the elution, a large fraction of the peptide was 
stuck on top of the column.
A constant ionic strength elution was then performed. 
Initially, it wa3 observed that at u*.2 MOPS, 3 peaks were 
observed. Two fractions came off first. The third peak was 
eluted using u».5 MOPS (Figure 7)* Spectra of the eluted 
peak3 indicated three distinct species (Figure 8). It 
was believed that the second peak contained HP-11. Attempts 
to replicate this run, however, failed. Instead, it was 
observed that in many instances, a significant portion of the 
peptide was stuck to the top of the column.
A test-tube assay was then developed to determine the 
proper ionic strength for elution. Initially, MOPS buffer 
had been used. However, MRS buffer was substituted so that 
the elutiuu pH would be one unit above the isoelectric 
point i HP-11 (pi-4.75) (24). The net result may be seen
13
in Table I and Figure 9a* As can be seen, the greatest 
dissociation occurs between u*.45 and u»#50 ME3.
However, complete dissociation, even at high ionic strengths 
did not occur#
Two sets of DEAE chromatography columns were then set up 
to test the validity of the test tube assay# It was found, 
however, that the MBS columns did not elute very well# On 
the other hand, the DEAE column at u«.45 MOPS gave a good 
separation, resulting in four distinct bands# However, 
a significant portion of the peptide was still stuck on top (Fig. 9b)#
The inability of the DEAE columns to completely elute 
the HP-11 sample even at high ionic strengths led us to 
suspect that the peptide might be precipitating on top of 
the column. Our conclusion was supported through several 
observations made during the course of the purification:
1) HP-11 samples precipitated out in solution with tine
at high ionic strength. 2) Leas peptide stuck to the 
column if a high ionic strength buffer was used to knock it 
off the column right away-decreasing the time for precipitation 
to occur. 3) Isoelectric focusing of our P-2 purified HP-11 
and Sigma HP-1 I revealed that both HP-11 samples did not 
move significantly from the applicator atrip (2. Pitluk,, 
personal communication-23). In addition, Ehrenberg and 
'fheorell have imported that HP-11 precipitates in low ionic 
strength from pH 4.4- to 7.1 (26). Therefore, when MBS 
buffer (pH*5.75) was used to improve the elution, the lowered 
pH probably precipitated the peptide more. In addition, it 
was initially thought that because DEAE is an anion exc&nger, 
a low pH would remove the peptide from the column. The 
contrary was found.
Figure -ionic strength gradient mixer for DEAR 
gradient elution
HTherefore, it appears that HP-11 precipitates out of solution 
at the eluting pH* Using this information, several procedures 
for purifying HP-11 in the future are outlined: 1) A test
tube assay similar to the procedure used for determining 
the ionic strength should be performed at various pH to 
confirm whether the heme peptide reaiiy does precipitate 
at t>H 4 to 7. A similar assay may then be used to determine 
the correct ionic strength for elution (24)* 2) A completely
different method of purification employing fractional 
precipitation may be used* The digest may be successively 
precipiated at higher and higher ionic strengths* The pellet 
obtained in each case can be analyzed to determine if it contains 
HP-11. The correct pellet may then be dissolved in HgO and 
eluted using a P-2 column as before-completely eliminating 
the need for DEAE purification.
The procedure for P-2 elution has been determined. However, 
Lh’JU') purification did not yield consistent results due to 
possible precipitation at the eluting pH (pH=7*Q). Two 
procedures for further purification are outli ed.
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Figure 6-Spectra of peaks eluted from P-2 column (Fig. 4c)
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Figure 7-DEA.E elutions
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Figure 8-Spectra of peaks eluted from DEAE using u=.2 MOPS, 
u*.5 MOPS
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Table 1-Test Tube Assay for Ionic Strength
Figure 9-Assays for determining oorreot u for 
DBAS elution
9a) Plot of u vs, % Unbound for test tube 
assay
9b) Picture of u * ,45 MOPS showing four 
distinct bands
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Tablo 1 i ■i’ube <\nn.iy for Ionic Strength
ionic strength Aw (c o n tr ° l)
-405 54 Unbound
.OQS 1.67 .015 .807
.OS 1.77 .044 'VO
.10 1.66 .030 1.8
.15 1.64 .060 4.2
. 20 1 .50 .10 6.8
.25 1.70 .19 11.2
.30 1.67 .31 18.8
.35 1.74 .40 22.9
.40 1.71 .45 26.3
.45 1.76 .49 28.1
.50 1.72 .66 58.5
Figure 9a
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Spectral Analysis of HP-11
A.
The spectral properties of cytochrome c have been extensively 
studied. In general, it has been determined that five spectrally 
distinct forms of cytochrome c exist at various pH, In 
addition, cytochrome c does not does not bind appreciably 
to ligands such as carbon monoxide» flouride ion, cyanide, 
or azide except at pH less than 2,5 or greater than 12,
The inability of cytochrome c to bind other ligands has been 
attributed to the lack of available coordination positions 
and the inaccessibility of the heme environment (27),
HP-11, on the other hand, has a relatively unshielded 
heme and a free sixth coordination position. As a result, 
heme agglutination and ligand binding occur readily. The 
purpose of this study, then, is to study these two properties 
of HP-11 in detail. Heme agglutination will be studied 
through concentration dependence studies, time dependent 
depolymerization, pH dependent polymerization, and ionic 
strength studies. In addition, ligand binding will be explored 
through imidazole binding in both reduced and oxidized HP-11 
at various pH, cyanide binding, CO binding, and lysine binding.
B. Material, ac£ ffrthgflp
1. flag Agglutination
a. Concentration Studies
Sigma HP-11 (10 mg/ml) was diluted approximately 30 fold 
before use. A series of test tubes was then set up ranging 
from most concentrated (256x) to least concentrated (x).
Bach concentration was obtained simply by 1:1 dilutions
23
of the next concentrated tube, A u*.Q1 MOPS/MOPS baseline 
was run. The more concentrated samples (]j32x) were measured 
using a 1 mm cuvette. The less concentrated samples were 
measured using 1 cm cuvettes. All measurements were made 
using a Carey 219 Spectrophotometer from 600-230 nm.
b. U°)£ dependence
A dilute sample (2.7 x 10”° M) of HP-11 Sigma standard 
was allowed to sit in a 1 era cuvette over a period of 
20 hours. At t - 0,1,3,7,20 hoursf a snectrum of the sample 
was taken. A I^O/^O baseline was used (430-350 nm).
c. sM, Studies
Degassed chloroacetic acid (pH ■ 2.3), MOPS (pH * 7*0), and 
bjric acid (pH « 9.2) all at u * .01 were made up (5,28).
A concentrated sample of P-2 purified HP-11 in H was diluted 
40 fold by the appropriate buffer. Three baselines (chloroacetic/ 
chloroacetic), (MOPS/MOPS), (boric/boric) were run. All 
measurements were made between 600-230 nm.
d. Ionic Strength
Solutions of varying ionic strengths ranging from H20 to 
u « Q.5 MOPS were made up in increments of u * .10. In order 
to achieve the desired ionic strength, an appropriate amount 
of NaClO^ was added to a stock solution of u * .05 MOPS (pH ■ 7*0). 
A concentrated sample of P-2 purified HP-11 in H90 was then 
diluted 40 fold by the appropriate ionic strength buffer.
A new baseline was run for each ionic strength measurement.
2• Ligand Binding
a. Imidazole
A 200-fold excess of solid imidazole was added to 
2 x 10~5 M solution of P-2 purified HP-11 in u » 0.1 MOPS*
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A concentration dependence study tie. carried out to 
determine if imidazole is a strong ligand*
In order to obtain the spectra of imidazole binding to 
oxidized HP-11 at various pH, a concentrated sample of 
HP-11 was diluted forty-fold in the appropriate buffer 
(chLoroacetic, MOPS, boric)* A 100-fold excess of imidazole 
was then added (final HP-11 concentration * 1*2 x 10*^ M).
Imidazole binding to reduced HP-11 was carried out 
in the following manner* The appropriate buffer was degassed 
before use, HP-11 was diluted 40 fold with the appropriate 
buffer* An oxidized HP-11 spectrum was taken (600-230 nm) 
in a 1 cm cuvette* A stopper fitting the mouth of the cuvette 
was inserted, and the solution was degassed for 10 minutes 
with argon* Another spectrum of deaerated HP-11 was taken. 
Solid sodium dithionite was then added to reduce the solution* 
A reduced spectrum was taken* Imidazole in 100-fold excess 
was then added to the reduced sample of HP-11 giving a 
reduced HP-11-imidazole (IHP) spectrum*
b. £N
A concentration dependence study was done using a 
200-fold excess of ON in u « 0.1 MOPS.
c. CO
HP-11 was reduced in a similar procedure to the reduced 
imidazole studiea* CO was bubbled through for five minutes. 
The buffer used was u « 0.1 MOPS, and the spectrum was 
taken from 600-350 nm.
d. tosine
A concentration dependence study was performed using 
1000 fold excess of lysine in u » .01 MOPS*
C. Results and Discussion 
1. Heme Agglutination
Figure 10 shows the spectra of HP-11 at various selected
concentrations• As can be seen, the absorption maximum shifts
from 526 run (25&x) to 516 run (x) in the visible region.
Moreover, the peal; gradually fades out w U h  increased dilution.
The Soret maximum shifus from 40r; nm for the most concentrated
sample to 3)0 run for the most dilute sample. At low concentrations
a peak was also observed in the UV region. This peak is
probably due to MOPS absorption (Figure 13). A plot of
extinction coefficient (£ « A max) vs. concentration was also
be
made (Figure 11). As expected, since the Soret maximum shifts 
witn concentration, the extinction coefficient also changes 
with increased dilution.
A similar result may be seen in a time-dependent shift of 
the Soret maximum in Figure 12. As can be seen, the Soret 
shifts from a maximum at 401 run (t = 0 hrs) to 359 nm (t * 20 hrs).
HP-11 of the same concentration at various pH also show 
similar shifts in the Soret and visible maxima as in the 
concentration dependence studies. Figure 13 shows the spectra 
of the buffers used in the study using a HgO/HgO baseline.
Figure 14 shows HP-11 of the same concentration (1.4 x 10 5 M) 
at three different pH. As can be seen, HP-11 at high pH 
(pH » 9.2) has a spectrum resembling HP-11 at high concentrations. 
At low pH (pH » 2.3)* HP-11 has a Soret maximum that is shifted 
even further down than HP-11 at low concentrations.
Not only is there a pH dependent transition of the 
Soret and visible region maxima, an ionic strength dependent
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shift in maxima was also observed. Figure 15 shows HI-11 
of the same concentration at various ionic strengths*
As can be seen, the Soret maximum of HP-11 In u =» 0.5 M0P0 
resembles that of HP-11 at high concentrations.
The above data has been heavily supported by the literature 
Concentration dependence ari time dependence shifts of the 
Joret have been obser 14). in addition, pH dependent 
transitions have also buon studied (10,29). The model that has 
been constructed to explain those observations involves pH 
dependent heme polymerizations. iiP-11 is known to undergo 
three pH-induced transitions with ;>K values of 5.4, 5#&, and 7.6 
These transitions have been interpreted in the following way 
(Figure 1b). Below pH 3f the magnetic moment of HP-11 
indicates the presence of hydroxo-bridged dimers of low-spin 
iron (ill). However, line (1) shows that when the imidazole 
group is dej vo, lated, it effectively displaces one of the 
water rnoieeuiu., leading to the optical transition with pK of 
3.4. In line (II), the o* -amino group of valine is deprotonated 
and binds intermoleeularly to a heme group leading to an 
optical transition with pK of 5.o, and a spin change in the 
iron to the low-3pin iron (III). In line (III), the £ -NHg 
group of lysine-13 is now free to polymerize with the heme 
group leading to an optical transition with pK of 7.6 (10,19).
This model can be used to account for some of my data.
At pH 7.0, heme? agglutination by the ^-NHg group of valine-11 
and to a lesser extent, the £ -NHp group of lysine-13 can occur.
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Therefore, at higher concentrations, there is a greater chance
for polymerization to occur, arm the :ioret maximum shifts to 
40^ nm. As the heme peptide is successively diluted, the 
weaker ligand HgO is now able to bind to the sixth coordination 
position and displace other heme peptides-Leading to a shift
to 396 nm. The same effect occurs for the tune dependence 
shift. With time, the molecule will be able to displace
an <*-NH0 group of valin r-1i. )nee it is bound, H.h) will 
not be displaced (17).
My pH studies indicate that at pH 2.3f the 3oret 
shifts in the direction of monomeric HP-11. At pH 9.2, the 
Soret shifts towards polymeric HP-11. These data, of course, 
do not constitute proof for heme polymerization at higher 
pH. However, studies have been performed in which sedimentation 
experiments indicate that the molecular weight of the heme 
peptide in acid solutions (pH » 2.3) have a molecular weight of 
approximate] r 2000 (HP-11 M.W. ■ 1^79). At high pH (pH * 8.7), 
however, the molecular weight was calculated to be approximately 
11,000 (9). Therefore, at low pH, the oC-NHg group of valine-11 
and the t-NH^ group of lysine-13 are both protonated and no 
polymerization occurs. However, at high pH both groups are 
able to coordinate effectively and heme agglutination occurs readily.
Heme agglutinatior can also be used to explain my ic ic 
strength studios. Paleus, Ehrenberg and Tuppy have reported 
that the spectrum of HP-11 is not altered by chloride ions at 
low pH (29). However, my ionic strength studies indicate 
that a change does occur at pH 7*0. These two observations can
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bo accounted for in the following manner# At low pH,
increased ionic strength does not order and precipitate the 
home peptide since intermolecular coordination cannot occur#
How. .ver, at higher nil, in ;ermolecular coordination can occur#
The increased ionic strength then serves to order the heme 
peptides and cause polymerisation*
Another question Chat may be asked deals with the relative 
orientation of the heme groups during agglutination# Does the 
heme peptides polymerize in a head-to-tail fashion or in a 
stacked configuration? Difference absorbance studies indicate 
that the orientation is indeed head-to-tai1-leading to a 
hyperchromia shift it higher concentrations ('50)#
An issue in heme agglutination that has not been completely 
resolved is whether the c*-NH0 groan of valine-‘1 does most
c
c° the polymerization at pH 7 or the £ -NIL, group of lysine-13*
Citing studies using optical rotatory dispersion, circular
dichroism, and difference absorbance measurements, Urry (30,31) showed
that HP-8, which lacks lysine-15, does not undergo polymerization#
Therefore, he believes that it is the £ -NH2 group of ly.sine-13
that is involved in heme polymerisation# Harbury and Loach
have carried out an acetylation the groups of HP-11
and shown that a monomeric form exists (14). Others,
including Wilson, et al., believe that it is the *-NH2
group of valine-11 since it has a lower intrinsic pK value
than the £ -NH2 group of lysine-13# In addition, they believe
that HP-8 does not polymerize because the oC -NH^ group of
cysteine-14 is too sterically hindered (19) (Figure 1)#
I believe that this issue may be resolved in several 
ways# Harbury and Loach carried out an acetylation which I
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have tried to duplicate* The conditions used were very harsh 
and the acetylatfrd HP-11 that they received was probably 
modified at both the d-NH2 group of valine-11 and the£-NH2 
group of lysine* Therefore , one procedure might involve the 
specific acetylation of the £-NH2 group of lysine-13. 
Concentration dependence and pH dependent studies may then 
be performed to determine if polymerization does occur*
In addition, HP-9 offers an unique structure for studying 
heme agglutination.(Figure 1). HP-9 has the sterically hindered 
<*-NH2 group of cysteine-14, but it also has an g-amino 
group of lys-22* Therefore, a concentration dependence 
study may be performc? i pH 5.0, in which thec^-NHg group 
is thought to coordin t I f  no polymerization occurs, a 
similar concentration - ondence study may be performed 
at pH 9*0* At this p , the £-NH2 group of lysine-22 should be 
deprotonated and poly ''ization effects should be observed*
A comparison may the’ < made with HP-11 in which polymerization
i3 observed at either mi and HP-8f in which no polymerization 
should be observed at either pH* Of course, aotual determination 
of the pK values of HP- * will be more accurate. However, 
the above procedure is relatively simple to do.
2* Ligand Binding
Figure 17 show' a oncentration dependence study of 
imidazule binded to HP-11 (IHP). As can be seen, imidazole is 
a strong ligand since no shift in the Goret maximum occurs.
A plot of concentration vo. extinction coefficient shows that 
the extinction coefficient is essentially constant (Figure 11).
A study of imidazole binding of oxidized and reduced HP-11 
at various pH wa3 als conducted* At pH 7.0,
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imidazole shifts the Soret maximum to 406 nm, indicating the 
presence of nitrogenous bases in the 5th and 6th coordination 
positions (14). Addition of imidazole to reduced HP-11 causes an 
increase in the absorption maxima of the visible region and the 
Soret. However, the Soret maximum did not shift appreciably 
from the reduced HP-11. In addition, imidazole also causes 
a significant decrease in absorbance at the UV range due to 
dithionite absorption (Figure 18f Figure 13).
At pH 2.3, imidazole does not shift the Soret maximum of 
oxidized HP-11 (394 nm). HP-11 "reduced” with dithionite did 
not show the characteristic maxima in the visible region. In 
addition, the Soret maximum remained at 394 nm with no shift 
to 418 nm as in pH 7*0. Moreover, addition of imidazole also 
did not have much of an effect except for increasing the 
absorbance (Figure 19).
At pH 9.2, imidazole does not shift the Soret maximum 
of oxidized HP-11 (406 nm). Imidazole added to reduced HP-11 
did not shift the maxima in the Soret and visible regions. In 
addition, the absorbance did not increase appreciably as in 
pH 7.0 (Figure 20).
The above observations mjaty be explained in the following 
manner. At pH 7.0, imidazole binds strongly to the hems center- 
displacing H2O or other heme peptides and causing the Soret 
maximum to shift to 406 nm. At pH 2.3, however, imidazole is 
protonated and doe not bind appreciably to HP-11. As a result, 
no shift in the Soret maximum is ob3erv i. At pH 9.2, imidazole 
probably binds to HP-11. However, since the absorbance maximum 
is at 406 nm already, addition of imidazole appears to have 
no effect.
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Reduced HP-11 presents a more interesting study. Reduced 
HP-11 has lower absorbance maxima in the visible region than 
cytochrome c, This decreased absorbance has been attributed 
to the fact that HP-11 contains only one ligand per iron atom 
compared to cytochrome c. Addition of histidine has been found 
to increase the visible region maxima (9), The same effect 
was observed at pH 7.0 when imidasol* was added. However, 
at pH 9.2f when there are already two ligands per iron atom due 
to home polymerization, imidazole does not increase the absorbance 
maxima of the visible region appreciably. At pH 2.3, HP-11 is 
probably not even reduced, Warme has reported that dithionite 
is denatured at pH 4.9 (17). Therefore, not only is the heme 
peptide not reduced at low pH, but the imidazole does not 
even bind to it.
Another strong ligand to HP-11 is CN. Figure 17b shows 
that CN binds strongly to oxidized HP-11 since concentration 
dependence studies show no shift in the Soret maximum from 
410 nm. A plot of concentration vs, extinction coefficient 
shows that the extinction coefficient does not change appreciably 
(Figure 11). A binding constant of 3,6 x 10^ M~1sec~1 has 
been calculated for cyanide binding to HP-11 (10),
CO is another HP-11 ligand that has been studied extensively 
(6,13). Reduced HP-11 binds CO strongly-shifting the Soret 
maximum from 416 nm to 409 nm. In addition, the characteristic 
maxima in the visible region diminish in intensity with a 
disappearance of the two well-;characterized peaks.
Lysine at pH 7*0 does not bind appreciably to HP-11.
Figure 22 shows that the Soret maximum shifts with concentration 
dilutions even at a 1000 fold excess lysine. This observation 
may be explained simply. At pH 7.0, both the ^-HH2
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and the & -NH2 group of lysine are protonated. No binding 
can occur*
D*
HP-11 differs from cytochrome c in that the sixth coordination 
position is free for ligand binding* Heme agglutination occurs 
through intermolecular pH dependent coordination by the & -NH2 
group of valine-11 and oc -NH2 group of lysine-13* In addition, 
imidazole, CN, CO, and lysine as ligands have been studied.
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Figure 17-Ligand Binding
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